Page last updated: 2024-11-05

4-methylphenylhydrazine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

4-Methylphenylhydrazine is an organic compound with the formula CH3C6H4NHNH2. It is a colorless to pale yellow liquid that is soluble in water and organic solvents. It is a derivative of phenylhydrazine, with a methyl group at the para position. It is synthesized by reacting 4-methylaniline with sodium nitrite in the presence of an acid. 4-methylphenylhydrazine is used as a reagent in organic synthesis, particularly in the synthesis of pharmaceuticals and agrochemicals. It is also used as a reagent in the analysis of carbohydrates. The compound is studied extensively for its reactivity and potential applications. It can be utilized in the synthesis of various complex molecules, including pharmaceuticals and agrochemicals. The compound has also been shown to exhibit biological activity, including antitumor and antimicrobial activity.'

4-methylphenylhydrazine: RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID10875
CHEMBL ID3884912
SCHEMBL ID8096
MeSH IDM0074514

Synonyms (49)

Synonym
ns424488w5 ,
3-15-00-00676 (beilstein handbook reference)
unii-ns424488w5
BB 0249744
ENAMINE_005596
p-tolylhydrazine
(4-methylphenyl)hydrazine
brn 0742270
hydrazine, (4-methylphenyl)-
einecs 208-717-2
4-methylphenylhydrazine
p-methylphenylhydrazine
hydrazine, p-tolyl-
STK400006
539-44-6
AKOS000269059
HMS1409O08
1-p-tolylhydrazine hydrochloride
A8770
p-tolyl-hydrazine
p-tolylhydrazinehydrochloride
A829849
AM804175
p-tolyl hydrazine hcl
FT-0600374
111007-30-8
SCHEMBL8096
paratolylhydrazine
4-methyl-phenylhydrazine
4-tolylhydrazine
paramethylphenylhydrazine
para-tolylhydrazine
4-hydrazinyltoluene
1-(4-methylphenyl)hydrazine #
J59.888G ,
DTXSID80202166
1-(4-methylphenyl)hydrazine
n-p-methylphenylhydrazine
methylphenylhydrazine, 4-
F2121-0390
mfcd00060553
p-tolylhydrazin
AS-54875
CHEMBL3884912
CS-0110658
n-4-methylphenylhydrazine
Q26841264
(r)-n-[2,3-dihydro-1-[2-(2-methylphenyl)-2-oxoethyl]-2-oxo-5-phenyl-1h-1,4-benzodiazepin-3-yl]-n-(3-methylphenyl)-urea
W10666
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID588519A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities2011Antiviral research, Sep, Volume: 91, Issue:3
High-throughput screening identification of poliovirus RNA-dependent RNA polymerase inhibitors.
AID1337095Inhibition of human MPO2017ACS medicinal chemistry letters, Feb-09, Volume: 8, Issue:2
From Dynamic Combinatorial Chemistry to
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (4)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.72

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.72 (24.57)
Research Supply Index1.79 (2.92)
Research Growth Index4.51 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.72)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]